DCTY Biotech Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$26.3M
DCTY Biotech General Information
Description
Researcher of tumor molecular-targeted cellular immunotherapy drugs designed for oncology treatment. The company focuses on R&D of tumor molecular targeted specific cellular immunotherapy drugs and technologies as well as operating a modern molecular biology, cell biology laboratory and detection platform, enabling the development and promotion of tumor molecular targeting specific cellular immunotherapy technology.
Contact Information
Website
www.taiyuanshengwu.comCorporate Office
- Building 4, No. 86, Shuangying West Road
- Nanshao, Changping District
- Beijing, 102200
- China
Corporate Office
- Building 4, No. 86, Shuangying West Road
- Nanshao, Changping District
- Beijing, 102200
- China
DCTY Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 09-Nov-2024 | $26.3M | Completed | Generating Revenue | ||
| 2. Later Stage VC | 14-Jan-2022 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 05-Jul-2021 | Completed | Generating Revenue |
DCTY Biotech Patents
DCTY Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025140683-A1 | Engineered immune cell expressing chemokine 10 and interleukin 15 | Inactive | 29-Dec-2023 | ||
| AU-2024268481-A1 | Tcr molecule targeting kras g12v mutation, cell, and uses thereof | Pending | 06-May-2023 | ||
| EP-4660206-A1 | Tcr molecule targeting kras g12v mutation, cell, and uses thereof | Pending | 06-May-2023 | ||
| US-20260250388-A1 | Tcr molecule targeting kras g12v mutation, cell, and uses thereof | Pending | 06-May-2023 | ||
| WO-2024230630-A1 | Tcr molecule targeting kras g12v mutation, cell, and uses thereof | Inactive | 06-May-2023 | C07K14/7051 |
DCTY Biotech FAQs
-
When was DCTY Biotech founded?
DCTY Biotech was founded in 2014.
-
Where is DCTY Biotech headquartered?
DCTY Biotech is headquartered in Beijing, China.
-
What industry is DCTY Biotech in?
DCTY Biotech’s primary industry is Biotechnology.
-
Is DCTY Biotech a private or public company?
DCTY Biotech is a Private company.
-
What is the current valuation of DCTY Biotech?
The current valuation of DCTY Biotech is .
-
What is DCTY Biotech’s current revenue?
The current revenue for DCTY Biotech is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process